Clinical Trial Site

Tokyo 183-8561

2 studies enrolling now · 8 studies all time

What they study most

ALA Dehydratase Deficient Porphyria (ADP), ANCA-Associated Vasculitis, AQP4+ NMOSD, Acute Hepatic Porphyria, Acute Intermittent Porphyria, Acute Porphyria, Atypical Hemolytic Uremic Syndrome (aHUS), Genetic Disease, Hereditary Coproporphyria (HCP), Kidney Diseases, NMOSD, Neuromyelitis Optica Spectrum Disorder

Studies at this site

• TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy — Recruiting now
• Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies — Recruiting now
• Long Term Extension Study in Patients With Primary Hyperoxaluria — Running, not enrolling
• A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis — Completed
• A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed
• ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) — Completed
• Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS) — Completed
• Trial of Andexanet in Patients Receiving an Oral FXa Inhibitor Who Require Urgent Surgery — Stopped early